Suppr超能文献

电子健康记录嵌入的成人镰状细胞病血管闭塞性发作急诊科治疗个性化疼痛计划:实施前和实施后研究方案

Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.

作者信息

Luo Lingzi, King Allison A, Carroll Yvonne, Baumann Ana A, Brambilla Donald, Carpenter Christopher R, Colla Joseph, Gibson Robert W, Gollan Siera, Hall Greg, Klesges Lisa, Kutlar Abdullah, Lyon Matthew, Melvin Cathy L, Norell Sarah, Mueller Martina, Potter Michael B, Richesson Rachel, Richardson Lynne D, Ryan Gery, Siewny Lauren, Treadwell Marsha, Zun Leslie, Armstrong-Brown Janelle, Cox Lisa, Tanabe Paula

机构信息

Washington University School of Medicine, St Louis, MO, United States.

St Jude Children's Research Hospital, Memphis, TN, United States.

出版信息

JMIR Res Protoc. 2021 Apr 16;10(4):e24818. doi: 10.2196/24818.

Abstract

BACKGROUND

Individuals living with sickle cell disease often require aggressive treatment of pain associated with vaso-occlusive episodes in the emergency department. Frequently, pain relief is poor. The 2014 National Heart, Lung, and Blood Institute evidence-based guidelines recommended an individualized treatment and monitoring protocol to improve pain management of vaso-occlusive episodes.

OBJECTIVE

This study will implement an electronic health record-embedded individualized pain plan with provider and patient access in the emergency departments of 8 US academic centers to improve pain treatment for adult patients with sickle cell disease. This study will assess the overall effects of electronic health record-embedded individualized pain plans on improving patient and provider outcomes associated with pain treatment in the emergency department setting and explore barriers and facilitators to the implementation process.

METHODS

A preimplementation and postimplementation study is being conducted by all 8 sites that are members of the National Heart, Lung, and Blood Institute-funded Sickle Cell Disease Implementation Consortium. Adults with sickle cell disease aged 18 to 45 years who had a visit to a participating emergency department for vaso-occlusive episodes within 90 days prior to enrollment will be eligible for inclusion. Patients will be enrolled in the clinic or remotely. The target analytical sample size of this study is 160 patient participants (20 per site) who have had an emergency department visit for vaso-occlusive episode treatment at participating emergency departments during the study period. Each site is expected to enroll approximately 40 participants to reach the analytical sample size. The electronic health record-embedded individualized pain plans will be written by the patient's sickle cell disease provider, and sites will work with the local informatics team to identify the best method to build the electronic health record-embedded individualized pain plan with patient and provider access. Each site will adopt required patient and provider implementation strategies and can choose to adopt optional strategies to improve the uptake and sustainability of the intervention. The study is informed by the Technology Acceptance Model 2 and the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework. Provider and patient baseline survey, follow-up survey within 96 hours of an emergency department vaso-occlusive episode visit, and selected qualitative interviews within 2 weeks of an emergency department visit will be performed to assess the primary outcome, patient-perceived quality of emergency department pain treatment, and additional implementation and intervention outcomes. Electronic health record data will be used to analyze individualized pain plan adherence and additional secondary outcomes, such as hospital admission and readmission rates.

RESULTS

The study is currently enrolling study participants. The active implementation period is 18 months.

CONCLUSIONS

This study proposes a structured, framework-informed approach to implement electronic health record-embedded individualized pain plans with both patient and provider access in routine emergency department practice. The results of the study will inform the implementation of electronic health record-embedded individualized pain plans at a larger scale outside of Sickle Cell Disease Implementation Consortium centers.

TRIAL REGISTRATION

ClinicalTrials.gov NCT04584528; https://clinicaltrials.gov/ct2/show/NCT04584528.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/24818.

摘要

背景

镰状细胞病患者在急诊科通常需要积极治疗与血管阻塞性发作相关的疼痛。然而,疼痛缓解情况往往不佳。2014年美国国立心肺血液研究所的循证指南推荐采用个体化治疗和监测方案,以改善血管阻塞性发作的疼痛管理。

目的

本研究将在美国8个学术中心的急诊科实施一项嵌入电子健康记录的个体化疼痛计划,供医护人员和患者使用,以改善成年镰状细胞病患者的疼痛治疗。本研究将评估嵌入电子健康记录的个体化疼痛计划对改善急诊科环境下与疼痛治疗相关的患者和医护人员结局的总体效果,并探索实施过程中的障碍和促进因素。

方法

由美国国立心肺血液研究所资助的镰状细胞病实施联盟的所有8个站点开展一项实施前和实施后的研究。年龄在18至45岁之间、在入组前90天内曾因血管阻塞性发作到参与研究的急诊科就诊的成年镰状细胞病患者将符合纳入条件。患者将在诊所或通过远程方式入组。本研究的目标分析样本量为160名患者参与者(每个站点20名),他们在研究期间因血管阻塞性发作治疗到参与研究的急诊科就诊。每个站点预计将招募约40名参与者以达到分析样本量。嵌入电子健康记录的个体化疼痛计划将由患者的镰状细胞病医护人员编写,各站点将与当地信息学团队合作,确定建立可供患者和医护人员使用的嵌入电子健康记录的个体化疼痛计划的最佳方法。每个站点将采用所需的患者和医护人员实施策略,并可选择采用可选策略,以提高干预措施的接受度和可持续性。本研究以技术接受模型2以及覆盖、有效性、采用、实施和维持框架为依据。将进行医护人员和患者基线调查、在急诊科血管阻塞性发作就诊后96小时内进行随访调查,以及在急诊科就诊后2周内进行选定的定性访谈,以评估主要结局、患者感知的急诊科疼痛治疗质量以及其他实施和干预结局。电子健康记录数据将用于分析个体化疼痛计划的依从性以及其他次要结局,如住院和再入院率。

结果

该研究目前正在招募研究参与者。积极实施期为18个月。

结论

本研究提出了一种结构化的、基于框架的方法,在常规急诊科实践中实施可供患者和医护人员使用的嵌入电子健康记录的个体化疼痛计划。研究结果将为在镰状细胞病实施联盟中心以外的更大范围内实施嵌入电子健康记录的个体化疼痛计划提供参考。

试验注册

ClinicalTrials.gov NCT04584528;https://clinicaltrials.gov/ct2/show/NCT04584528。

国际注册报告识别码(IRRID):DERR1-10.2196/24818。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8215/8087964/0f10f553f79e/resprot_v10i4e24818_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验